Efficacy Evaluation of Thymosin Alpha 1 in Non-severe Patients With COVID-19: A Retrospective Cohort Study Based on Propensity Score Matching

Objective: Thymosin alpha 1 (Thymosin-α1) is a potential treatment for patients with COVID-19. We aimed to determine the effect of Thymosin-α1 in non-severe patients with COVID-19. Methods: We retrospectively enrolled 1,388 non-severe patients with COVID-19. The primary and secondary clinical outcom...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, ChenLu, Fei, Ling, Xu, Wei, Li, WeiXia, Xie, XuDong, Li, Qiang, Chen, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102900/
https://www.ncbi.nlm.nih.gov/pubmed/33968969
http://dx.doi.org/10.3389/fmed.2021.664776

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102900/
https://www.ncbi.nlm.nih.gov/pubmed/33968969
http://dx.doi.org/10.3389/fmed.2021.664776

Ejemplares similares